Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study

Turan Erdoğan1, Sinan Altan Kocaman, Mustafa Çetin

  • 1Departments of Cardiology, Faculty of Medicine, Rize University, Rize-Turkey. sinanaltan@gmail.com.

Insights

YKL-40 levels are significantly higher in patients with coronary artery ectasia (CAE) compared to normal arteries. This inflammatory marker, YKL-40, was identified as the sole determinant of CAE, suggesting its potential role in the condition.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation

Background:

  • Coronary artery ectasia (CAE) has an unclear cause, potentially linked to intense inflammation.
  • YKL-40 is an inflammatory biomarker secreted by macrophages in atherosclerotic plaques.

Purpose of the Study:

  • To investigate YKL-40 and C-reactive protein (CRP) levels in patients with isolated CAE.
  • Compare these levels against patients with normal coronary arteries (NCA) and coronary artery disease (CAD).

Main Methods:

  • Observational, cross-sectional study design.
  • Included 49 patients with isolated CAE, 30 with NCA, and 30 with CAD.
  • Analyzed YKL-40 and CRP levels using univariate and multiple logistic regression.

Main Results:

  • Serum YKL-40 levels were significantly higher in CAE (144±68 μg/L) and CAD (180±117 μg/L) groups compared to the NCA group (110±53 μg/L).
  • C-reactive protein (CRP) levels did not differ significantly among the groups.
  • Logistic regression identified YKL-40 level as the sole determinant of CAE (OR: 1.010, p=0.027).

Conclusions:

  • Patients with isolated CAE exhibit significantly elevated YKL-40 levels compared to those with NCA.
  • YKL-40 is established as the independent determinant of CAE.
  • Further research is warranted to elucidate the causative role of YKL-40 in isolated CAE.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...